NCT00617253 Combination of Recombinant Human IL-21 (rIL-21) and Sunitinib in Stage IV Renal Cell Carcinoma Patients Status COMPLETED Phase PHASE2
NCT00614120 Effect of Liraglutide or Glimepiride Added to Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00614055 Comparison of Two NN5401 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT00613951 Comparison of Two NN5401 Formulations Versus Biphasic Insulin Aspart 30, All in Combination With Metformin in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT00612599 Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 50 to Biphasic Insulin Aspart 70 in Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00612040 Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Insulin Aspart in Subjects With Type 1 Diabetes Status COMPLETED Phase PHASE2
NCT00611884 Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT00607737 Applications Site Reactions After Injection of Insulin Detemir and Saline in Subjects With Diabetes Status COMPLETED Phase PHASE4
NCT00605111 Efficacy and Safety of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT00605020 Efficacy and Safety of Insulin Detemir in Combination With Insulin Aspart and Biphasic Insulin Aspart 30 in Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00604656 Comparison of Insulin Aspart Produced by the NN2000 Process to the Current Process in Type 1 Diabetes Status COMPLETED Phase PHASE3
NCT00604396 Safety and Efficacy of Insulin Detemir in Combination With OAD in Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00604344 Efficacy and the Safety of Insulin Detemir in Subjects With Insulin Requiring Diabetes Status COMPLETED Phase PHASE3
NCT00604253 Efficacy and Safety of Insulin Detemir in Type 2 Diabetes Inadequately Controlled on OHA Therapy Alone Status COMPLETED Phase PHASE3
NCT00601861 Effect of rIL-21 on Metastases in Lymph Nodes in Melanoma Skin Cancer Status TERMINATED Phase PHASE2
NCT00600626 Basal Bolus of Insulin Aspart Including Insulin NPH and Biphasic Insulin Aspart in Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00600366 Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen® in Insulin Naive Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT00598793 Biphasic Insulin Aspart 30 in Type 2 Diabetes Failing OAD Therapy Status COMPLETED Phase PHASE3